April 18, 2018 / 12:09 PM / a month ago

BRIEF-Opiant Pharmaceuticals Awarded Grant Of Approximately $7.4 Mln From The National Institutes Of Health

April 18 (Reuters) - Opiant Pharmaceuticals Inc:

* OPIANT PHARMACEUTICALS AWARDED GRANT OF APPROXIMATELY $7.4 MILLION FROM THE NATIONAL INSTITUTES OF HEALTH FOR DEVELOPMENT OF OPNT003, INTRANASAL NALMEFENE, FOR TREATMENT OF OPIOID OVERDOSE

* OPIANT PHARMACEUTICALS-GRANT INCLUDES ABOUT $2.6 MILLION TO BE FUNDED FOR PERIOD ENDING MARCH 31, 2019, WITH BALANCE TO BE FUNDED OVER SUBSEQUENT 2 YEARS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below